GGrantIndex
Sort

51,593 grants matching hepatitis

Glycosyltransferase Function in Development and Disease

$438,750
Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · DK

Glycosyltransferase Function in Development and Disease

$438,750
Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · DK

HLA restriction and TCR affinity in HIV

$438,750
Daniel Garrett Kavanagh · Massachusetts General Hospital · R56 · FY2011 · AI

Glycosyltransferase Function in Development and Disease

$438,750
Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · DK

DEFECTIVE INTERFERENCE OF HEPADNAVIRUS IN NATURE

$438,709
University Of Texas Medical Br Galveston · R01 · FY2003 · CA

Funtional T-cell Failure in Chronic HCV Infection

$438,683
Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2009 · AI

Functions of the Nuclear Receptor SHP

$438,666
Baylor College Of Medicine · R01 · FY2005 · DK

The Role of FcRn in Echovirus Entry and Pathogenesis

$438,653
Carolyn B Coyne · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI

The Role of FcRn in Echovirus Entry and Pathogenesis

$438,653
Carolyn B Coyne · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Regulation of Iron Homeostasis by BMP Signaling

$438,650
Jodie L Babitt · Massachusetts General Hospital · R01 · FY2010 · DK

INBRE: WINTHROP U: FACULTY & UNDERGRADUATE RESEARCH DEVELOPMENT

$438,634
Patrick Owens · University Of South Carolina At Columbia · P20 · FY2010 · RR

TRIM mediated host antiviral responses during influenza virus infections

$438,624
Adolfo Garcia-Sastre · University Of Southern California · U19 · FY2010 · AI

Mechanisms of Silymarin Hepatoprotection

$438,615
Stephen J. Polyak · University Of Washington · R01 · FY2014 · AT

Mechanisms of Silymarin Hepatoprotection

$438,615
Stephen J. Polyak · University Of Washington · R01 · FY2015 · AT

Mechanisms of Silymarin Hepatoprotection

$438,614
Stephen J. Polyak · University Of Washington · R01 · FY2013 · AT

INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTION

$438,581
Weill Medical College Of Cornell Univ · U01 · FY2001 · AI

IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION

$438,577
Donald A. McClain · University Of Utah · R01 · FY2009 · DK

Metabolic and xenobiotic control of thyroid hormone metabolism

$438,571
Antonio C Bianco · University Of Texas Med Br Galveston · R01 · FY2025 · DK

Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network

$438,547
Evan L Fogel · Indiana University Indianapolis · U01 · FY2023 · DK

GENE THERAPY FOR DYSLIPIDEMIA AND ATHEROSCLEROSIS

$438,506
Daniel James Rader · University Of Pennsylvania · P01 · FY2007 · HL

Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program

$438,490
Shruti H Mehta · Johns Hopkins University · T32 · FY2023 · AI

Development of CB1 Monoclonal Antibodies for Treating NASH

$438,450
Benjamin Jacob Doranz · Integral Molecular · R44 · FY2018 · DK

Role of ABCG5 and ABCG8 in Sterol Metabolism

$438,432
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2011 · HL

The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and Damage

$438,397
Heather L Francis · Indiana University Indianapolis · R01 · FY2022 · DK

International Collaborative of prospective studies of HIV and Hepatitis in IDU

$438,391
Kimberly Page · University Of California, San Francisco · R01 · FY2012 · DA